Provided by Tiger Trade Technology Pte. Ltd.

SELLAS Life Sciences Group Inc.

1.74
0.0000
Post-market: 1.770.0300+1.72%19:59 EST
Volume:4.28M
Turnover:7.47M
Market Cap:247.08M
PE:-6.19
High:1.80
Open:1.73
Low:1.69
Close:1.74
52wk High:2.48
52wk Low:0.7720
Shares:142.00M
Float Shares:142.00M
Volume Ratio:0.91
T/O Rate:3.01%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.2813
EPS(LYR):-0.5046
ROE:-84.33%
ROA:-44.90%
PB:5.41
PE(LYR):-3.45

Loading ...

Director Katherine Bach Kalin Acquires Common Shares of Sellas Life Sciences Group Inc

Reuters
·
Nov 21

SELLAS Life Sciences Q3 Net Income USD -6.791 Million

Reuters
·
Nov 20

SELLAS Life Sciences Q3 net loss narrows to $6.8 mln

Reuters
·
Nov 13

BRIEF-SELLAS Life Sciences Q3 Net Income USD -6.791 Million

Reuters
·
Nov 13

Press Release: SELLAS Life Sciences Reports Third Quarter 2025 Financial Results and Provides Corporate Update

Dow Jones
·
Nov 13

Sellas Life Sciences options imply 12.3% move in share price post-earnings

TIPRANKS
·
Nov 13

Papa John's Is Not First: Here Are 3 Other Stocks Rocked By Market-Moving Fake News

Benzinga_recent_news
·
Nov 11

Sellas Life Sciences Group Inc expected to post a loss of 7 cents a share - Earnings Preview

Reuters
·
Nov 07

Ero Announces Result of Year-Long Value-Creation Initiative at Xavantina, Commences First Gold Concentrate Sales in Q4 2025

GlobeNewswire
·
Nov 04

Sellas Life Sciences Unveils Phase 2 Data for SLS009 Combo in Relapsed AML at ASH 2025

Reuters
·
Nov 03

Sellas Life Sciences Raises $31 Million From Exercise of Warrants

MT Newswires Live
·
Oct 27

BRIEF-SELLAS Life Sciences Group Announces Exercise of Existing Warrants Held by a Current Institutional Investor for $31 Million in Gross Proceeds

Reuters
·
Oct 27

SELLAS Life Sciences to Participate in the J.P. Morgan U.S. Opportunities Forum

GlobeNewswire
·
Oct 22

Evonik Partners with Schneider Electric: New Products Reduce Carbon Emissions by 70% and Enable 3D Printing Applications

Deep News
·
Oct 14

NASA has a wild plan to return astronauts to the moon. Here’s why experts are starting to worry

Bloomberg
·
Oct 14

SELLAS Life Sciences to Present In Vivo Preclinical Data Demonstrating Statistically Significant Survival Benefit of SLS009 in T-Cell Prolymphocytic Leukemia at the European Society for Medical Oncology (ESMO) Congress 2025

GlobeNewswire
·
Oct 13

Sellas Life Sciences files to sell 19.69M shares of common stock for holders

TIPRANKS
·
Oct 11

Sellas Life Sciences Group Inc: Files for Resale by Selling Stockholders of up to an Aggregate of 19.7 Mln Shares of Common Stock - SEC Filing

THOMSON REUTERS
·
Oct 11

Is SELLAS Life Sciences Group (NASDAQ:SLS) In A Good Position To Invest In Growth?

Simply Wall St.
·
Oct 08

Sellas Life Sciences Group Extends Times Square Tower Sublease Through September 2027

Reuters
·
Oct 04